Literature DB >> 32531099

Sexual impairment in patients with hidradenitis suppurativa: a systematic review.

C Cuenca-Barrales1, T Montero-Vílchez1,2, J C Szepietowski3, L Matusiak3, A Molina-Leyva1,2.   

Abstract

Hidradenitis suppurativa (HS) can cause considerable impact on several aspects of quality of life. Sexuality is a central aspect of quality of life. In recent years, there has been an increase in the number of articles on HS and sexuality. To achieve our aim of synthesizing the available scientific evidence on HS and sexual health, we conducted a systematic review in February 2020. The clinical databases used included Medline and Embase. All types of epidemiological articles were included; reviews, guidelines, protocols, conference abstracts and case report articles were excluded. Eleven studies were included for review, representing 42 729 patients with HS. The most common study design was cross-sectional with or without comparison group(s), conducted in an outpatient setting or through surveys. Prevalence of sexual dysfunction ranged between 51-62%, and in the case of erectile dysfunction, a specific kind of sexual dysfunction affecting penile erection, it ranged from between 52% and 60% of patients studied using validated questionnaires. Potential risk factors for sexual dysfunction among men and women were identified, mainly related to disease activity, symptoms and partners. Mood disorders like depression and anxiety appear to be associated with sexual dysfunction. Women were more affected by sexual distress. HS patients with sexual dysfunction had a decreased overall quality of life. With respect to treatment, surgery did not improve sexual function and there is no scientific evidence regarding medical treatments. Patients stated that they would like to treat their sexual problems with healthcare professionals. In conclusion, sexual and erectile dysfunction are common in HS patients, and negatively affect their quality of life. There are clinical factors potentially associated with this which should be identified and treated by dermatologists in the comprehensive care of HS patients. Prospective studies are needed to provide more scientific evidence on this unmet need.
© 2020 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2020        PMID: 32531099     DOI: 10.1111/jdv.16726

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  5 in total

1.  Reproductive Potential and Outcomes in Patients with Hidradenitis Suppurativa: Clinical Profile and Therapeutic Implications.

Authors:  Trinidad Montero-Vilchez; Luis Salvador-Rodriguez; Andrea Rodriguez-Tejero; Manuel Sanchez-Diaz; Salvador Arias-Santiago; Alejandro Molina-Leyva
Journal:  Life (Basel)       Date:  2021-03-26

2.  Sexuality in Patients with Hidradenitis Suppurativa: Beliefs, Behaviors and Needs.

Authors:  Carlos Cuenca-Barrales; Alejandro Molina-Leyva
Journal:  Int J Environ Res Public Health       Date:  2020-11-27       Impact factor: 3.390

3.  Hidradenitis suppurativa and suicide risk: a multivariate analysis in a disease with a high psychological burden.

Authors:  José Juan Pereyra-Rodríguez; Giovana Fernanda Osorio-Gómez; Juan Ortiz-Álvarez; Juan Carlos Hernández-Rodríguez; Antonio José Durán-Romero; Julián Conejo-Mir Sánchez
Journal:  Arch Dermatol Res       Date:  2022-09-15       Impact factor: 3.033

Review 4.  Sexual Dysfunction and Atopic Dermatitis: A Systematic Review.

Authors:  Laura Linares-Gonzalez; Ignacio Lozano-Lozano; Luis Gutierrez-Rojas; Mario Lozano-Lozano; Teresa Rodenas-Herranz; Ricardo Ruiz-Villaverde
Journal:  Life (Basel)       Date:  2021-11-29

Review 5.  Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review.

Authors:  Maria-Angeles Ferrer-Alcala; Manuel Sánchez-Díaz; Salvador Arias-Santiago; Alejandro Molina-Leyva
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.